M. Nissilä

1.4k total citations
50 papers, 899 citations indexed

About

M. Nissilä is a scholar working on Rheumatology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, M. Nissilä has authored 50 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Rheumatology, 11 papers in Pharmacology and 9 papers in Psychiatry and Mental health. Recurrent topics in M. Nissilä's work include Rheumatoid Arthritis Research and Therapies (19 papers), Migraine and Headache Studies (9 papers) and Inflammatory mediators and NSAID effects (9 papers). M. Nissilä is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (19 papers), Migraine and Headache Studies (9 papers) and Inflammatory mediators and NSAID effects (9 papers). M. Nissilä collaborates with scholars based in Finland, United States and France. M. Nissilä's co-authors include H Isomäki, Marjatta Leirisalo‐Repo, K. Lehtinen, J. Martio, Aarno Palotie, Kaisa Granfors, Reijo Luukkainen, U. I. Yli-Kerttula, Maija Wessman and Mikko Kallela and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Neurology.

In The Last Decade

M. Nissilä

48 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Nissilä Finland 18 448 224 125 119 115 50 899
Maria Chiara Gerardi Italy 14 263 0.6× 196 0.9× 162 1.3× 47 0.4× 110 1.0× 37 803
Aryeh M. Abeles United States 14 249 0.6× 260 1.2× 183 1.5× 157 1.3× 204 1.8× 20 964
Mahir Uğur Türkiye 16 371 0.8× 70 0.3× 137 1.1× 72 0.6× 87 0.8× 37 688
Veli Çobankara Türkiye 16 308 0.7× 82 0.4× 114 0.9× 97 0.8× 50 0.4× 106 874
L. Färber Germany 19 94 0.2× 145 0.6× 174 1.4× 182 1.5× 174 1.5× 44 889
L. Altomonte Italy 17 320 0.7× 42 0.2× 98 0.8× 134 1.1× 58 0.5× 69 879
R. Bach Andersen Denmark 16 177 0.4× 127 0.6× 39 0.3× 116 1.0× 91 0.8× 34 859
Ji‐Hyoun Kang South Korea 15 410 0.9× 67 0.3× 157 1.3× 56 0.5× 87 0.8× 67 700
Tatiana Reitblat Israel 12 276 0.6× 70 0.3× 168 1.3× 72 0.6× 43 0.4× 43 591
Valeria Nucera Italy 12 166 0.4× 117 0.5× 97 0.8× 26 0.2× 60 0.5× 19 477

Countries citing papers authored by M. Nissilä

Since Specialization
Citations

This map shows the geographic impact of M. Nissilä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Nissilä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Nissilä more than expected).

Fields of papers citing papers by M. Nissilä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Nissilä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Nissilä. The network helps show where M. Nissilä may publish in the future.

Co-authorship network of co-authors of M. Nissilä

This figure shows the co-authorship network connecting the top 25 collaborators of M. Nissilä. A scholar is included among the top collaborators of M. Nissilä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Nissilä. M. Nissilä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffmann, Jan, Holger Kaube, Florian Rimmele, et al.. (2025). Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine. Neurology. 104(3). e210220–e210220. 1 indexed citations
2.
3.
4.
Häppölä, Paavo, Padhraig Gormley, Ville Artto, et al.. (2021). Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families. Cephalalgia. 42(4-5). 345–356. 8 indexed citations
5.
Purmonen, Timo, Samu Kurki, Minna A. Korolainen, et al.. (2021). Erenumab Decreases Headache-Related Sick Leave Days and Health Care Visits: A Retrospective Real-World Study in Working Patients with Migraine. Neurology and Therapy. 11(1). 223–235. 9 indexed citations
6.
7.
Korolainen, Minna A., Samuli Tuominen, Samu Kurki, et al.. (2020). Burden of migraine in Finland: multimorbidity and phenotypic disease networks in occupational healthcare. The Journal of Headache and Pain. 21(1). 8–8. 15 indexed citations
8.
Korolainen, Minna A., Samu Kurki, Mariann I. Lassenius, et al.. (2019). Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care. The Journal of Headache and Pain. 20(1). 13–13. 31 indexed citations
9.
Artto, Ville, Maija Wessman, M. Nissilä, et al.. (2006). Comorbidity in Finnish migraine families. The Journal of Headache and Pain. 7(5). 324–330. 18 indexed citations
10.
Kaunisto, Mari, Mikko Kallela, Suzanne M. Leal, et al.. (2004). Chromosome 19p13 loci in Finnish migraine with aura families. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 132B(1). 85–89. 17 indexed citations
11.
Lemmel, E.‐M., W. Bolten, Rubén Burgos‐Vargas, et al.. (1997). Efficacy and safety of meloxicam in patients with rheumatoid arthritis.. PubMed. 24(2). 282–90. 35 indexed citations
12.
Mäki‐Ikola, O., M. Nissilä, K. Lehtinen, et al.. (1995). ANTIBODIES TO KLEBSIELLA PNEUMONIAE, ESCHERICHA COLIAND PROTEUS MIRABILISIN THE SERA OF PATIENTS WITH AXIAL AND PERIPHERAL FORM OF ANKYLOSING SPONDYLITIS. Lara D. Veeken. 34(5). 413–417. 15 indexed citations
13.
14.
Salo, Matti & M. Nissilä. (1990). Cell‐mediated and humoral immune responses to total hip replacement under spinal or general anaesthesia. Acta Anaesthesiologica Scandinavica. 34(3). 241–248. 21 indexed citations
15.
Nissilä, M., K. Lehtinen, Marjatta Leirisalo‐Repo, et al.. (1988). Sulfasalazine in the treatment of ankylosing spondylitis. Arthritis & Rheumatism. 31(9). 1111–1116. 93 indexed citations
16.
Seppälä, Erkki, K. Lehtinen, H Isomäki, et al.. (1988). Effects of antirheumatic drugs on renal function and eicosanoid excretion. Scandinavian Journal of Rheumatology. 17(sup67). 17–17. 2 indexed citations
17.
Nissilä, M., et al.. (1988). Activity of Natural Killer Cells after Postoperative Amino Acid Infusion. Journal of Parenteral and Enteral Nutrition. 12(4). 346–350. 5 indexed citations
18.
Laitinen, Ossi, Erkki Seppälä, M. Nissilä, & Heikki Vapaatalo. (1983). Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis. Clinical Rheumatology. 2(4). 401–406. 6 indexed citations
19.
Nissilä, M., J Ahlqvist, Yrjö Collan, P Raúnio, & H Isomäki. (1977). Morphological Findings in Joint Cartilage After Osmic Acid Treatment. Scandinavian Journal of Rheumatology. 6(4). 231–236. 8 indexed citations
20.
Nissilä, M., et al.. (1977). Osmic Acid in Rheumatoid Synovitis: A Controlled Study. Scandinavian Journal of Rheumatology. 6(3). 158–160. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Chiara Gerardi Breakdown of academic impact, for papers by Aryeh M. Abeles Breakdown of academic impact, for papers by Mahir Uğur Breakdown of academic impact, for papers by Veli Çobankara Breakdown of academic impact, for papers by L. Färber Breakdown of academic impact, for papers by L. Altomonte Breakdown of academic impact, for papers by R. Bach Andersen Breakdown of academic impact, for papers by Ji‐Hyoun Kang Breakdown of academic impact, for papers by Tatiana Reitblat Breakdown of academic impact, for papers by Valeria Nucera
Rankless by CCL
2026